Lunquan Sun

16PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer geneticsCancer cell biologyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 17, 2026
MAP2K6 reprograms NAD+ metabolism via the HMGA1-NAMPT axis to sensitize ovarian cancer cells to PARP inhibition.

|Mar 12, 2025
CD44+ cells enhance pro-tumor stroma in the spatial landscape of colorectal cancer leading edge.

Feiyu Tang, Yongwei Zhu, Jia Shen

|Mar 08, 2025
Cellular polarity pilots breast cancer progression and immunosuppression.

Jie Huang, Shufeng Luo, Juan Shen

|Mar 02, 2025
PPDPF-mediated regulation of BCAA metabolism enhances mTORC1 activity and drives cholangiocarcinoma progression.

Zhi Li, Yidi Guan, Jie Gao

|Nov 08, 2024
Enhancing low-dose radiotherapy efficacy with PARP inhibitors via FBL-mediated oxidative stress response in colorectal cancer.

Ming Wen, Yanfang Qiu, Meng Wang

|Aug 29, 2024
Correction for Hu et al., "Mast Cell-Induced Lung Injury in Mice Infected with H5N1 Influenza Virus".

Yanxin Hu, Yi Jin, Deping Han

Pageof 3

Frequent Collaborators

4 joint publications

Liang Weng

2 joint publications

Yuezhen Deng

2 joint publications

Zhi Li

2 joint publications

Jian Jian Li